An anti-infective drug discovery platform is essential for developing new treatments against bacterial, viral, fungal, and parasitic infections. This platform integrates advanced technologies such as high-throughput screening, molecular modeling, and phenotypic assays to identify and optimize potential drug candidates. Researchers use it to study pathogen biology, host-pathogen interactions, and resistance mechanisms. By accelerating the discovery of novel therapeutics, this platform plays a critical role in addressing global health challenges, including emerging infectious diseases and antimicrobial resistance.